We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Smoking Increases the Risk of Ectopic Pregnancy

By HospiMedica International staff writers
Posted on 17 Jul 2012
A new study suggests that cigarette smoke reduces the production of a Fallopian tube gene, which could help explain the link between smoking and ectopic pregnancy. More...


Researchers at the Medical Research Council (MRC, Edinburgh, United Kingdom) exposed cells from the Fallopian tube to a breakdown product of nicotine called cotinine. They then showed that cotinine had a negative effect on genes known to be associated with cell death (or apoptosis), and in particular with the BCL2-associated agonist of cell death (BAD) gene, which normally undergoes expression reduction in the cells of the uterus just before the embryo implants.

In a further study the researchers showed that BAD expression was reduced in the Fallopian tube of women who were smokers due exposure to cotinine, resulting in an environment similar to that of the uterus as it prepares for normal implantation of the embryo and early pregnancy, thus encouraging and allowing ectopic pregnancy to occur. The study was presented at the European Society of Human Reproduction and Embryology (ESHRE) annual meeting, held during July 2012 in Istanbul (Turkey).

“The research is exciting because it provides new scientific evidence to help understand why women who smoke are more likely to have ectopic pregnancies,” said study presenter and coauthor Andrew Horne, MD, of the MRC Center for Reproductive Health. “The information gained from this study can also be applied to other conditions caused by smoking, and could help us prevent or treat them better in the long term.”

Ectopic pregnancy occurs in up to 2% of all pregnancies, and is the most common cause of maternal death in early pregnancy. It transpires when the embryo implants outside the uterus and in the fallopian tube. Currently there is no way to prevent an ectopic pregnancy, and the condition must be treated by abdominal surgery or, when the ectopic is small and stable, by injection of methotrexate (MTX) to abort.

Related Links:

Medical Research Council (MRC)




Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical System
Stealth AXiS
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image:The NCIBT team with the cath lab members celebrating the completion of the study. (Image Credit: UC Davis)

Dual-Imaging Catheter Completes Initial Human Evaluation of Coronary Plaque

Atherosclerosis involves plaque buildup in arterial walls that can narrow blood vessels and increase the risk of heart attack, stroke, and other serious cardiovascular conditions. In coronary arteries,... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.